Cargando…
Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer
The thyroid is the most common site of endocrine cancer. One type of thyroid cancer, non-medullary thyroid cancer (NMTC), develops from follicular cells and represents approximately 90% of all thyroid cancers. Approximately 5%–15% of NMTC cases are thought to be of familial origin (FNMTC), which is...
Autores principales: | Hińcza, Kinga, Kowalik, Artur, Kowalska, Aldona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678600/ https://www.ncbi.nlm.nih.gov/pubmed/31247975 http://dx.doi.org/10.3390/genes10070482 |
Ejemplares similares
-
Late-Onset Medullary Thyroid Cancer in a Patient with a Germline RET Codon C634R Mutation
por: Walczyk, Agnieszka, et al.
Publicado: (2021) -
Immune Profiling of Medullary Thyroid Cancer—An Opportunity for Immunotherapy
por: Hińcza-Nowak, Kinga, et al.
Publicado: (2021) -
CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer
por: Hińcza-Nowak, Kinga, et al.
Publicado: (2023) -
Are molecular tests necessary to diagnose NIFTP?
por: Kuchareczko, Artur, et al.
Publicado: (2021) -
Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?
por: Hińcza, Kinga, et al.
Publicado: (2020)